A Meta-Analysis of Amputation Risk in empagliflozin studies (1245.25, 1245.110, 1245.121)

ENCePP Code of conduct

No

Data sources

• Data sources (types):
  Other
• Data sources (types), other:
  Randomised, placebo-controlled, double-blind, parallel-group, and event-driven clinical trials: 1245.25, 1245.110, and 1245.121

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No